Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes
Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at least 10% weight reduction as compared to 23.1% among those prescribed semaglutide for T2D, 28.6% liraglutide for obesity, and 12.3% liraglutide for T2D groups.